Close Menu

A study published in this month's issue of the American Journal of Medical Genetics by researchers at Signature Genomic Laboratories shows that the company can identify patients with Pallister-Killian disorder using DNA from blood rather than the more invasive skin biopsy that is routinely used.

The development is in line with a general trend in molecular cytogenetics of using array-based methods to replace older technologies.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.